Detection method of alpha-tocopherol bacterial endotoxin based on recombinant C factor method and application thereof
Through ultrasonic treatment and recombinant factor C method, quantitative detection of α-tocopherol bacterial endotoxin is achieved, solving the problems of low detection efficiency and insufficient accuracy in the prior art, and providing an efficient and low-cost detection solution.
Patent Information
- Application Number
- CN202411190590.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-28
- Publication Date
- 2024-11-26
AI Technical Summary
In the prior art, the endotoxin detection method using seahorse horseshoe crab blood cells as reaction raw materials has problems such as nonspecific interference, batch stability problems and environmental pollution, making it difficult to achieve high-efficiency and low-cost quantification of endotoxins of α-tocopherol bacteria. Test.
Using ultrasonic treatment method, α-tocopherol is evenly dispersed in pyrogen-free water, and bacterial endotoxin is completely released into the aqueous solution by standing. Fluorescence determination is carried out in combination with the recombinant factor C method to achieve the bacterial endotoxin of α-tocopherol. Quantitative detection.
This method improves detection efficiency and accuracy, avoids interference from the nature of the test product on the detection, provides higher specificity and precision, and ensures the stability and repeatability of the test results.
Smart Images

Figure CN119023967A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of endotoxin detection, and in particular to a detection method of alpha-tocopherol bacterial endotoxin based on a recombinant factor C method and an application thereof. Background Art
[0002] The amoeba cells of horseshoe crabs are extremely sensitive to endotoxins. The endotoxin detection method using horseshoe crab reagents made from horseshoe crab blood amoeba cell lysates has been used in the medical field since the mid-1970s. It was soon widely adopted by countries around the world and was established as a legal bacterial endotoxin test method. After decades of development and improvement, the horseshoe crab reagent endotoxin detection method has been applied to various fields such as pharmaceuticals, medical devices, water quality, food testing, and scientific research. However, the use of horseshoe crab blood cell lysates with complex components as reaction raw materials has insurmountable defects. For example, nonspecific interference problems, batch stability problems, environmental pollution, etc. With the rapid growth in demand for injectable drugs and medical devices for humans and animals, it has become increasingly important to develop alternative methods for the rapid and reliable quantitative detection of endotoxins.
[0003] Horseshoe crab factor C is a serine protease procathectomy that is sensitive to bacterial endotoxins in horseshoe crab blood cells. In the horseshoe crab blood agglutination system mediated by bacterial endotoxins, horseshoe crab factor C is the first to be activated by endotoxins to initiate the blood agglutination cascade reaction in the entire horseshoe crab blood cells. Recombinant factor C that is bound and activated by endotoxins can cleave the substrate to obtain free fluorescent groups. The release of fluorescent groups is proportional to the concentration of endotoxins, thereby allowing endotoxins to be quantitatively detected. Compared with the classic horseshoe crab reagent endotoxin test method, the recombinant factor C endotoxin test method has higher specificity, better specificity, precision, accuracy, linear range and quantitative limit, and is an improved method for the current horseshoe crab reagent endotoxin test method.
[0004] α-Tocopherol is a fat-soluble vitamin with many important physiological functions, such as anti-free radical, anti-aging, prevention of skin keratinization, improvement of physical immunity and cellular immunity of humans and animals, prevention and treatment of cardiovascular and cerebrovascular diseases, etc. Therefore, it is favored by consumers in the pharmaceutical, food, nutritional health products and cosmetics industries.
[0005] Since the fluorescence determination method is used, the test solution needs to be clear and transparent to reduce interference with the fluorescence reading. α-Tocopherol is in an oily liquid state and is insoluble in water, so a method needs to be invented to release the bacterial endotoxins in α-tocopherol and ensure that its aqueous solution does not interfere with the fluorescence reading. Therefore, a method for detecting α-tocopherol bacterial endotoxins is needed, which can also avoid the shortcomings of the rabbit pyrogen method and the horseshoe crab reagent method, and detect bacterial endotoxins efficiently and at low cost to meet the needs of injection and its raw material and auxiliary material detection.
[0006] In summary, how to fully release the endotoxin of α-tocopherol bacteria is an urgent problem to be solved. Summary of the invention
[0007] In order to solve the above technical problems, the present invention provides a method for detecting α-tocopherol bacterial endotoxin based on the recombinant C factor method and its application. The present invention adopts an ultrasonic method to fully release the bacterial endotoxin in α-tocopherol. The method can realize the quantitative detection of α-tocopherol bacterial endotoxin, the method is feasible, and the inspection efficiency is high.
[0008] To achieve this object, the present invention adopts the following technical solutions:
[0009] In a first aspect, the present invention provides a method for detecting α-tocopherol bacterial endotoxin based on a recombinant factor C method, the steps of the detection method comprising: ultrasonically treating a test sample, allowing the test sample to stand to obtain a test sample solution, preparing a series of standard solution, adding a fluorescent substrate for incubation, and then detecting;
[0010] The frequency of the ultrasound is 30-40kHz, and the time is 1-3h. The 30-40kHz may be, for example, 30kHz, 31kHz, 32kHz, 33kHz, 34kHz, 35kHz, 36kHz, 37kHz, 38kHz, 39kHz or 40kHz, etc. The 1-3h may be, for example, 1h, 1.5h, 2h, 2.5h or 3h, etc.
[0011] The ultrasonic method used in the present invention can make α-tocopherol evenly dispersed in pyrogen-free water. After standing, the bacterial endotoxins in the α-tocopherol are all released into the aqueous solution. After detection, it is found that the bacterial endotoxins in the α-tocopherol are completely released. The detection method can effectively perform detection with high detection efficiency.
[0012] Preferably, after the ultrasonic treatment of the test sample, the solution is allowed to stand to separate into layers, and the clear liquid is removed to obtain a sample solution.
[0013] In the present invention, after ultrasonic treatment, the α-tocopherol solution presents a uniform turbid liquid state. During this process, bacterial endotoxins enter the aqueous solution, and after standing for stratification, the bacterial endotoxins are all retained in the aqueous solution of the lower layer. The content of bacterial endotoxins in the α-tocopherol can be known through detection. This method cleverly utilizes ultrasound to fully disperse the α-tocopherol to release the contained bacterial endotoxins. This method is simple and efficient.
[0014] Preferably, the concentration of the test solution is 0.001-0.05 g / mL, for example, it can be 0.001 g / mL, 0.005 g / mL, 0.01 g / mL, 0.02 g / mL or 0.05 g / mL.
[0015] Preferably, the sample solution is tested after gradient dilution.
[0016] Preferably, the maximum effective dilution factor of the test solution is calculated according to the following formula:
[0017] MVD = cL / λ;
[0018] Wherein, MVD is the maximum effective dilution multiple, c is the concentration of the test solution, L is the bacterial endotoxin limit of the test sample, and λ is the lowest bacterial endotoxin concentration on the standard curve.
[0019] Preferably, the bacterial endotoxin limit of the test sample is at least 2 EU / mg, for example, it can be 0.5 EU / mg, 1 EU / mg, 1.5 EU / mg or 2 EU / mg.
[0020] Preferably, the maximum effective dilution multiple of the test solution is in the range of 10-20000, and the dilution multiple of the test solution can be lower than 20000 times, for example, it can be 10 times, 40 times, 80 times, 100 times, 1000 times, 10000 times or 20000 times, etc.;
[0021] Preferably, the standing time is 16-24 hours, for example, 16 hours, 18 hours, 20 hours, 22 hours or 24 hours, etc.;
[0022] In the present invention, after ultrasound, α-tocopherol is fully dispersed in water to form a turbid solution. In this process, bacterial endotoxins are released. Due to the insoluble nature of α-tocopherol in water, the solution is gradually stratified. Within the above-mentioned static range, the solution stratification can be ensured to be complete. If it is smaller than this range, the solution stratification is incomplete, resulting in insufficient release of bacterial endotoxins in the detected solution and possible interference of α-tocopherol with the detection. If it is larger than this range, bacterial endotoxins may re-enter the α-tocopherol, resulting in distortion of the detection result.
[0023] Preferably, the detection method further comprises: detecting a series of standard solutions and preparing a standard curve;
[0024] Preferably, the standard series solutions are bacterial endotoxin working standard solutions;
[0025] Preferably, the concentration range of the standard series solutions is 0.005-5EU / mL, for example, it can be 0.005EU / mL, 0.05EU / mL, 0.1EU / mL, 0.5EU / mL, 1EU / mL, 2EU / mL, 3EU / mL, 4EU / mL or 5EU / mL.
[0026] Preferably, the incubation temperature is 36-38°C, for example, 36°C, 36.5°C, 37°C, 37.5°C or 38°C.
[0027] Preferably, the volume ratio of the test solution to the fluorescent substrate is 1:(0.5-1.5), and the (0.5-1.5) can be, for example, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4 or 1.5, etc.
[0028] Preferably, the test sample to be detected includes a diluted test sample solution and a diluted test sample solution to which a standard is added;
[0029] Preferably, the concentration of the standard added after dilution is 0.05-0.5EU / mL, for example, it can be 0.05EU / mL, 0.1EU / mL, 0.2EU / mL, 0.4EU / mL or 0.5EU / mL.
[0030] Preferably, the detection instrument comprises an ELISA reader.
[0031] Preferably, the detected temperature is 36-38°C, for example, it can be 36°C, 36.5°C, 37°C, 37.5°C or 38°C.
[0032] Preferably, the excitation wavelength of the detection is 380±5nm, and the emission wavelength is 440±5nm; preferably, the excitation wavelength of the detection is 380nm, and the emission wavelength is 440nm.
[0033] Preferably, the detection time includes before incubation and incubation for 1 hour.
[0034] Preferably, the detection also includes data analysis.
[0035] Preferably, the data analysis process includes: obtaining fluorescence difference, calibration, performing linear fitting to obtain endotoxin content in the sample, and calculating spike recovery rate.
[0036] Preferably, the calculation formula of the fluorescence difference includes: fluorescence difference = fluorescence value after incubation for 1 hour - fluorescence value before incubation.
[0037] Preferably, the calibration calculation formula includes: net fluorescence difference = fluorescence difference - fluorescence difference of negative control.
[0038] Preferably, the calculation formula of the spiked recovery rate includes: spiked recovery rate % = (endotoxin concentration spiked - endotoxin concentration not spiked) / concentration of the standard added to the test sample × 100%;
[0039] In a second aspect, the present invention provides an application of the method for detecting bacterial endotoxin of α-tocopherol based on the recombinant factor C method according to the first aspect in detecting bacterial endotoxin in α-tocopherol.
[0040] Compared with the prior art, the present invention has at least the following beneficial effects:
[0041] 1. The present invention eliminates the interference of the properties of the test sample itself on the detection by ultrasonic treatment until the solution becomes a uniform turbid liquid and then stands still until the solution is layered and the clear liquid is taken out, so that the endotoxin content detection tends to be stable and repeatable, and provides a practical solution for the endotoxin content detection of α-tocopherol.
[0042] 2. The method of the present invention does not rely on animal-derived ingredients and can provide higher supply security; the recombinant expression production has good batch-to-batch consistency of products; it has higher specificity, better specificity, precision, accuracy, linear range and quantitative limit. BRIEF DESCRIPTION OF THE DRAWINGS
[0043] Figure 1 is the fitted curve of bacterial endotoxin standards. DETAILED DESCRIPTION
[0044] The technical solution of the present invention is further described below in conjunction with the accompanying drawings and through specific implementation methods. However, the following examples are only simplified examples of the present invention and do not represent or limit the scope of protection of the present invention. The scope of protection of the present invention shall be subject to the claims.
[0045] The following are the sources of the experimental materials used in the examples:
[0046] Adamas life& Recombinant Factor C Endotoxin Detection Kit: Components include endotoxin working standard, fluorescent substrate solution, assay buffer, rFC enzyme solution, pyrogen-free water, batch number-RF010231202.
[0047] α-Tocopherol: Brand - Adamas life, Shanghai Titan Technology Co., Ltd., specification - 5g, product number - 016249149, CAS number - 59-02-9, batch number - P3043498.
[0048] Microplate reader: Thermo Fisher VL0000D0 Varioskan TM LUX multifunctional microplate reader.
[0049] Example 1
[0050] This embodiment provides a method for detecting α-tocopherol bacterial endotoxin based on the recombinant factor C method
[0051] (1) Sample processing
[0052] α-Tocopherol was used as the test sample. According to the calculation of MVD=cL / λ, the bacterial endotoxin limit was 2EU / mg. The MVD of 0.01g / mL test sample solution was 4000. 0.01g of the test sample was taken and 1mL of pyrogen-free water was added. The solution was ultrasonicated at a frequency of 35kHz for 3 hours until it became a uniform turbid liquid. The solution was then allowed to stand for 16 hours until the solution separated into layers. The clear liquid was taken as the test sample solution and diluted with pyrogen-free water to form a 10-fold and 40-fold test sample solution series dilution solution.
[0053] (2) Preparation of standard solution
[0054] The bacterial endotoxin standard was prepared into a series of standard solutions of 5.0EU / mL, 0.5EU / mL, 0.05EU / mL, and 0.005EU / mL.
[0055] (3) Sample addition
[0056] Adopt Adamas life& The recombinant factor C endotoxin detection kit was used for detection. The standard series solution, negative control, and test series dilution solution were added to a 96-well pyrogen-free white ELISA plate in sequence. The sample volume per well was 100 μL. The test series dilution solution needed to be added to a row of duplicate wells, and 10 μL of 5EU / mL standard series solution was added to one row of test series dilution solution. The 96-well plate with the sample was placed in a 37°C ELISA instrument and incubated for 10 minutes.
[0057] The fluorescent substrate solution, assay buffer and rFC enzyme solution balanced to room temperature were mixed in a ratio of 5:4:1 to prepare a fluorescent substrate mixed reagent. 100 μL of the fluorescent substrate mixed reagent was added to each well of the incubated 96-well plate and returned to the 37°C microplate reader.
[0058] (4) Detection
[0059] Adjust the detection parameters of the microplate reader to 380nm excitation wavelength and 440nm emission wavelength, and detect the RFU 0h ) and after 1 hour of incubation (RFU 1h ) fluorescence value.
[0060] Example 2
[0061] This embodiment provides a method for detecting α-tocopherol bacterial endotoxin based on the recombinant factor C method. The only difference from Example 1 is that 0.01 g of the test sample is taken, 900 μL of pyrogen-free water and 100 μL of a standard solution with a concentration of 5.0 EU / mL are added, and ultrasonic treatment is first performed until a uniform turbid liquid is formed, and then the solution is allowed to stand until the solution is separated into layers, and the clear liquid is taken as the sample liquid. The rest is consistent with Example 1.
[0062] Example 3
[0063] This comparative example provides a method for detecting α-tocopherol bacterial endotoxin based on the recombinant factor C method, which is different from Example 1 only in that the ultrasonic time is 1 hour, and the rest is consistent with Example 1.
[0064] Example 4
[0065] This comparative example provides a method for detecting α-tocopherol bacterial endotoxin based on the recombinant factor C method, which is different from Example 1 only in that the ultrasonic time is 2 hours, and the rest is consistent with Example 1.
[0066] Comparative Example 1
[0067] This comparative example provides a method for detecting α-tocopherol bacterial endotoxin based on the recombinant C factor method. The only difference from Example 1 is that the ultrasonic time is 0.5 h, the test sample is not mixed evenly with the pyrogen-free water, and the ELISA instrument cannot be used for detection. The rest is consistent with Example 1.
[0068] Comparative Example 2
[0069] This comparative example provides a method for detecting α-tocopherol bacterial endotoxin based on the recombinant factor C method. The only difference from Example 1 is that the ultrasonic method is replaced by an oscillation dissolution method. The specific operation is to take 0.01 g of the test sample, add 1 mL of pyrogen-free water, and oscillate on a vortex mixer for more than 2 minutes. The test sample is not evenly mixed with the pyrogen-free water and cannot be detected by an ELISA instrument.
[0070] Comparative Example 3
[0071] This comparative example provides a method for detecting α-tocopherol bacterial endotoxin based on the recombinant factor C method. The only difference from Example 1 is that the ultrasonic method is replaced by a heating dissolution method. The specific operation is to take 0.01g of the test sample, add 1mL of pyrogen-free water, and bathe in a water bath at 100°C for more than 2 minutes. The test sample is not evenly mixed with the pyrogen-free water and cannot be detected by an ELISA instrument.
[0072] Comparative Example 4
[0073] This comparative example provides a method for detecting α-tocopherol bacterial endotoxin based on the recombinant C factor method. The only difference from Example 1 is that the ultrasonic method is replaced by the anhydrous ethanol dissolution method. The specific operation is to take 0.01g of the test sample, add 1mL of anhydrous ethanol, and the test sample solution is clear and transparent. The rest is consistent with Example 1.
[0074] Comparative Example 5
[0075] This comparative example provides a method for detecting α-tocopherol bacterial endotoxin based on the recombinant C factor method. The only difference from Example 1 is that the ultrasonic method is replaced by the ethyl acetate dissolution method. The specific operation is to take 0.01g of the test sample, add 1mL of ethyl acetate, and the test sample solution is clear and transparent. The rest is consistent with Example 1.
[0076] Test Example 1
[0077] This test example is used to test the detection effect of the above examples 1-2 and comparative examples 1-7
[0078] First, the standard product is fitted with a curve. The specific results are as follows: Figure 1 As shown, the equation of the standard fitting curve is: log( 净ΔRFU )=1.0471log( 内毒素浓度 )+2.0465, reliability test results: R 2 =1.
[0079] The above examples and comparative examples were tested, RFU 1h Subtract RFU 0h The fluorescence difference (△RFU) obtained was obtained; the fluorescence reading difference (ΔRFU) of the standard and the test sample was calibrated with the fluorescence difference (ΔRFU) of the negative control to obtain the net fluorescence difference; the logarithm of the net fluorescence difference and the logarithm of the endotoxin concentration were calculated, and a plot was drawn and a linear fit was performed, R 2 Should be ≥0.980; calculate the endotoxin content of the test sample series dilution solution and the test sample spiked solution by fitting the curve, and calculate the spiked recovery rate: Spiked recovery rate % = (endotoxin concentration 加标 -Endotoxin concentration 未加标 ) / 0.5EU / mL×100%. The specific test results are shown in Tables 1 and 2.
[0080] Table 1
[0081]
[0082] Since the above calculation method could not be performed after the detection of Comparative Examples 4 and 5, the ΔRFU was negative, and the endotoxin concentration value and recovery rate value could not be obtained, so Table 2 only shows the fluorescence values of each dilution factor at 0h and 1h.
[0083] Table 2
[0084]
[0085] The results are shown in Table 1 and Table 2:
[0086] (1) By comparing Example 1 with Example 2, it can be seen that the method of treating α-tocopherol with ultrasonic stasis does not destroy the endotoxin in α-tocopherol, and can fully mix α-tocopherol with pyrogen-free water, and can fully release the bacterial endotoxin in α-tocopherol.
[0087] (2) By comparing Example 1 with Comparative Example 1, it can be seen that at the same ultrasonic frequency, if the ultrasonic time is too short, the α-tocopherol cannot be fully mixed with the pyrogen-free water, and the bacterial endotoxin in the α-tocopherol cannot be fully released.
[0088] (3) By comparing Example 1 with Comparative Examples 2-5, it can be seen that among the sample treatment methods such as ultrasound, oscillation dissolution, heating dissolution, anhydrous ethanol dissolution, and ethyl acetate dissolution, only ultrasound can fully mix α-tocopherol with pyrogen-free water, fully release the bacterial endotoxin in α-tocopherol, and realize the quantitative detection of α-tocopherol bacterial endotoxin.
[0089] In summary, the ultrasonic method is used to fully release the bacterial endotoxin in α-tocopherol. This method can realize the quantitative detection of α-tocopherol bacterial endotoxin. The method is feasible and has high inspection efficiency.
[0090] The applicant declares that the above is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Those skilled in the art should understand that any changes or substitutions that can be easily thought of by those skilled in the art within the technical scope disclosed by the present invention shall fall within the protection scope and disclosure scope of the present invention.
Claims
1. A method for detecting α-tocopherol bacterial endotoxin based on the recombinant factor C method, characterized in that: The detection method comprises the following steps: ultrasonically treating the test sample, allowing the test sample to stand to obtain a test sample solution, preparing a series of standard solution, adding a fluorescent substrate for incubation, and then detecting; The frequency of the ultrasound is 30-40 kHz, and the time is 1-3 h.
2. The detection method according to claim 1, characterized in that: After the ultrasonic treatment of the test sample, the solution is allowed to stand until the solution separates into layers, and the clear solution is removed to obtain the test sample solution; Preferably, the concentration of the test sample in the test solution is 0.001-0.05 g / mL; Preferably, the test solution is tested after gradient dilution.
3. The detection method according to claim 1 or 2, characterized in that: The maximum effective dilution factor of the test solution is calculated according to the following formula: MVD = cL / λ; Wherein, MVD is the maximum effective dilution multiple, c is the concentration of the test solution, L is the bacterial endotoxin limit of the test product, and λ is the lowest bacterial endotoxin concentration on the standard curve; Preferably, the bacterial endotoxin limit of the test article is at least 2EU / mg; Preferably, the maximum effective dilution factor of the test solution is 10-20000.
4. The detection method according to any one of claims 1 to 3, characterized in that: The standing time is 16-24h.
5. The detection method according to any one of claims 1 to 4, characterized in that: The detection method further comprises: detecting a series of standard solutions and preparing a standard curve; Preferably, the standard series solutions are bacterial endotoxin working standard solutions; Preferably, the concentration range of the standard series solutions is 0.005-5EU / mL.
6. The detection method according to any one of claims 1 to 5, characterized in that: The incubation temperature is 36-38°C; Preferably, the test sample to be detected includes a diluted test sample solution and a diluted test sample solution to which a standard is added; Preferably, the concentration of the standard added after dilution is 0.05-0.5EU / mL.
7. The detection method according to any one of claims 1 to 6, characterized in that: The detection instrument includes an ELISA reader; Preferably, the detected temperature includes 36-38°C; Preferably, the excitation wavelength of the detection is 380 nm and the emission wavelength is 440 nm; Preferably, the detection time includes before incubation and incubation for 1 hour.
8. The detection method according to any one of claims 1 to 7, characterized in that: The detection also includes data analysis; Preferably, the data analysis process includes: obtaining fluorescence difference, calibration, performing linear fitting to obtain endotoxin content in the test sample, and calculating spike recovery rate; Preferably, the calculation formula of the fluorescence difference includes: fluorescence difference = fluorescence value after 1 hour of incubation - fluorescence value before incubation; Preferably, the calculation formula for calibration includes: net fluorescence difference=fluorescence difference-fluorescence difference of negative control.
9. The detection method according to any one of claims 1 to 8, characterized in that: The calculation formula of the spike recovery rate includes: spike recovery rate % = (endotoxin concentration 加标 -Endotoxin concentration 未加标 ) / concentration of standard added to the test sample × 100%.
10. Use of the method for detecting bacterial endotoxin of α-tocopherol based on the recombinant factor C method according to any one of claims 1 to 9 in detecting bacterial endotoxin in α-tocopherol.
